Ensure Corona reports be available within 2 days: Delhi High Court

New Delhi: Delhi High Court asked the Delhi government to ensure that reports of Covid-19 tests conducted on suspected patients is available within 24-48 hours.

A bench of Justices Hima Kohli and Subramonium Prasad disposed a PIL filed by Advocate Rakesh Malhotra seeking directions to the Centre and the state government to ensure speedy testing of Covid-19 patients without any delay in providing the results.

Rakesh Malhotra said that, “Media reports showed that over the past month, the number of swab samples pending for tests in Delhi, which started with 470 on April1, had gone up by 7 times and reached 3,295, on April 29.”

On its part, the government informed the bench that to get faster results, it was sending samples to 23 labs — 13 private and 10 public sector — in the capital and not to Noida.

The state government placed an order issued by the Health and Family Department before the bench that said, “the notification in this regard had been extended by two weeks so that samples be sent within the capital instead of National Institute of Biologicals in Noida, where the testing process was slow leading to increase in pendency.”

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre